We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.67%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.4B
AUM Growth
+$4.58B
(+26%)
Cap. Flow
+$3.46B
Cap. Flow
% of AUM
15.44%
Top 10 Holdings %
Top 10 Hldgs %
18.61%
Holding
1,174
New
365
Increased
222
Reduced
249
Closed
328
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$455M |
| 2 |
AABA
Altaba Inc
AABA
|
+$237M |
| 3 |
Amazon
AMZN
|
+$185M |
| 4 |
DuPont de Nemours
DD
|
+$162M |
| 5 |
Danaher
DHR
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$158M |
| 2 |
JD.com
JD
|
+$125M |
| 3 |
Biogen
BIIB
|
+$114M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$110M |
| 5 |
Mastercard
MA
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.38% |
| 2 | Consumer Discretionary | 10.54% |
| 3 | Energy | 8.23% |
| 4 | Industrials | 8.1% |
| 5 | Communication Services | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Veeva Systems
VEEV
$30.3B
| $11.3M | 0.05% |
200,000
-25,900
| -11% | -$1.57M |
|
|
CELG
377
DELISTED
Celgene Corp
CELG
| $11.3M | 0.05% |
+77,242
| New | +$10.5M |
|
|
RDS.A
378
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $11.2M | 0.05% |
184,065
-337,173
| -65% | -$18.9M |
|
379
Yelp
YELP
$1.38B
| $11.1M | 0.05% |
256,900
-746,100
| -74% | -$28.8M |
|
|
SAGE
380
DELISTED
Sage Therapeutics
SAGE
| $11.1M | 0.05% |
178,350
+53,350
| +43% | +$4.19M |
|
381
Jazz Pharmaceuticals
JAZZ
$15.9B
| $10.9M | 0.05% |
74,700
+41,800
| +127% | +$6.32M |
|
|
ZNGA
382
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $10.9M | 0.05% |
2,881,437
+1,314,237
| +84% | +$4.84M |
|
|
UFS
383
DELISTED
DOMTAR CORPORATION (New)
UFS
| $10.8M | 0.05% |
248,157
+218,157
| +727% | +$8.7M |
|
|
CERN
384
CALL
DELISTED
Cerner Corp
CERN
| $10.7M | 0.05% |
+150,000
| New | +$9.95M |
|
385
Smith & Nephew
SNN
$12.9B
| $10.7M | 0.05% |
293,500
-76,400
| -21% | -$2.72M |
|
|
RTN
386
DELISTED
Raytheon Company
RTN
| $10.7M | 0.05% |
57,100
-214,669
| -79% | -$37.8M |
|
387
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $10.6M | 0.05% |
186,226
+86,226
| +86% | +$4.63M |
|
|
SGMO
388
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $10.4M | 0.05% |
693,300
+335,595
| +94% | +$3.71M |
|
389
Textron
TXT
$16.6B
| $10.4M | 0.05% |
192,800
-428,200
| -69% | -$21.3M |
|
|
SPR
390
DELISTED
Spirit AeroSystems
SPR
| $10.3M | 0.05% |
+132,900
| New | +$9.19M |
|
|
B
391
Barrick Mining
B
$62.2B
| $10.3M | 0.05% |
637,800
+196,700
| +45% | +$3.29M |
|
392
DHT Holdings
DHT
$2.97B
| $10.2M | 0.05% |
2,568,200
-1,243,000
| -33% | -$4.99M |
|
393
Summit Therapeutics
SMMT
$10.9B
| $10.1M | 0.05% |
806,471
+5,240
| +0.7% | +$67.9K |
|
394
Johnson Controls International
JCI
$87.5B
| $10.1M | 0.05% |
+250,000
| New | +$10.1M |
|
395
Ametek
AME
$55.5B
| $10M | 0.04% |
151,684
+47,214
| +45% | +$2.98M |
|
396
ConocoPhillips
COP
$147B
| $10M | 0.04% |
200,000
+28,400
| +17% | +$1.28M |
|
397
Alnylam Pharmaceuticals
ALNY
$36.3B
| $9.99M | 0.04% |
85,000
+35,000
| +70% | +$2.99M |
|
398
Healthcare Realty
HR
$7.42B
| $9.98M | 0.04% |
334,800
+25,600
| +8% | +$778K |
|
|
ARNA
399
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $9.97M | 0.04% |
+391,100
| New | +$8.97M |
|
400
Hilton Worldwide
HLT
$74B
| $9.97M | 0.04% |
143,589
-6,500
| -4% | -$414K |
|
Similar funds
CBU
BC
Point72 Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Point72 Asset Management held 1,174 positions worth $22.4B, up 26% from $17.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Point72 Asset Management deployed $3.46B of net new capital in Q3 2017, opening 365 new positions and adding to 222 existing holdings. Its largest new stake was Nebius Group N.V.: 3,618,469 shares worth $119M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Visa, an estimated $158M trimmed.
- Point72 Asset Management's largest Q3 2017 buy was Nebius Group N.V.: 3,618,469 shares worth $119M.
- Point72 Asset Management added most to Time Warner Inc in Q3 2017, an estimated $455M increase.
- Point72 Asset Management's biggest Q3 2017 reduction was Visa, cutting an estimated $158M.
- Point72 Asset Management fully exited Gilead Sciences in Q3 2017, selling an estimated $90.1M.
- Point72 Asset Management's ten largest holdings make up 19% of its $22.4B portfolio in Q3 2017.
- Point72 Asset Management opened 365 new positions and closed 328 in Q3 2017.
- Point72 Asset Management's portfolio value rose 26% quarter-over-quarter to $22.4B.
Based on Point72 Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.